Retatrutide is a new pharmaceutical in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, exhibits promising results in research studies. By activating these receptors, https://hannawawv418672.collectblogs.com/80975015/tirzepatide-a-promising-new-treatment-for-obesity